Memory Care Library Blog > Uncategorized > FDA approves new Alzheimer’s drug, offering hope for slower cognitive decline

FDA approves new Alzheimer’s drug, offering hope for slower cognitive decline

FDA approves new Alzheimer’s drug, offering hope for slower cognitive decline

Eli Lilly’s donanemab slows cognitive decline by a matter of months

https://www.cbc.ca/news/health/donanemab-fda-1.7226978

Leave a Reply

Your email address will not be published. Required fields are marked *

© All Right Reserved Memory Care Library Blog 2025

Theme One Elementor By PencilWp